
               
               
               7 DRUG INTERACTIONS
               
                  Whenever possible, agents which may enhance the risk of hemorrhage should be discontinued prior to initiation of enoxaparin sodium injection therapy. These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone. If co-administration is essential, conduct close clinical and laboratory monitoring [see Warnings and Precautions (5.9)
                     ].
                  
               
               
               
                  
                     
                        Discontinue agents which may enhance hemorrhage risk prior to initiation of Enoxaparin Sodium Injection or conduct close clinical and laboratory monitoring (5.9, 7).
                     
                  
               
            
         